Medicines for Hereditary Angioedema (HAE)
Status
Active
Submission Deadline
34 days remaining
Contracting authority
SYKEHUSINNKJØP HF35 more open tenders view
Location
Vadsø, Norway
Procedure
Open Procedure · Supplies
Category
Medical equipments, pharmaceuticals and personal care products.Pharmaceutical products.
Published
Reference
ted-588716-2026
Source
Supply of medicines with active ingredients for hereditary angioedema (HAE) disease under framework agreements. Included are the ATC groups: B06AC01 - C1 inhibitor, B06AC02 - Icatibant, B06AC04 - Conestat alfa, B06AC05 - Lanadelumab, B06AC06 - Berotralstat, B06AC07 - Garadacimab, B06AC08 - Sebetralstat, B06AC09 - Donidalorsen.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 588716-2026HTML
- TED PDF — 588716-2026PDF
- TED XML — 588716-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024